Johnny Kao

Radiation Oncology
1000 Montauk Hwy
West Islip, NY 11795

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Lymphocyte Kinetics and Outcomes After Comprehensive Involved-Site Radiotherapy for Oligometastases.

Lymphocyte Kinetics and Outcomes After Comprehensive Involved-Site Radiotherapy for Oligometastases.

Journal: Cancers
Published: May 06, 2026

Deep and durable prostate-specific antigen response following comprehensive involved site radiotherapy for prostate cancer oligometastases.

Deep and durable prostate-specific antigen response following comprehensive involved site radiotherapy for prostate cancer oligometastases.

Journal: Urologic oncology
Published: October 27, 2025

Publisher Correction: Long-term survival and undetectable circulating tumor DNA following comprehensive involved site radiotherapy for oligometastases.

Publisher Correction: Long-term survival and undetectable circulating tumor DNA following comprehensive involved site radiotherapy for oligometastases.

Journal: Scientific reports
Published: March 31, 2025

Ultrahypofractionated partial breast irradiation following oncoplastic surgery: secondary analysis of a phase II trial.

Ultrahypofractionated partial breast irradiation following oncoplastic surgery: secondary analysis of a phase II trial.

Journal: Radiation oncology (London, England)
Published: January 01, 2025

Phase 2 Trial of Ultrahypofractionated Image-guided Partial Breast Irradiation Following Lumpectomy with Optional Oncoplastic Reconstruction for Early-stage Breast Cancer.

Phase 2 Trial of Ultrahypofractionated Image-guided Partial Breast Irradiation Following Lumpectomy with Optional Oncoplastic Reconstruction for Early-stage Breast Cancer.

Journal: Advances in radiation oncology
Published: October 22, 2024

Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy.

Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy.

Journal: PloS one
Published: October 22, 2024

Long-term survival and undetectable circulating tumor DNA following comprehensive involved site radiotherapy for oligometastases.

Long-term survival and undetectable circulating tumor DNA following comprehensive involved site radiotherapy for oligometastases.

Journal: Scientific reports
Published: October 21, 2024

Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases.

Long-term disease-free survival following comprehensive involved site radiotherapy for oligometastases.

Journal: Frontiers in oncology
Published: August 01, 2023

Predicting long‑term survival following involved site radiotherapy for oligometastases.

Predicting long‑term survival following involved site radiotherapy for oligometastases.

Journal: Oncology letters
Published: May 13, 2023

Personalized Palliative and Survivorship Care for Patients With Metastatic Cancer Treated With Radiation Therapy.

Personalized Palliative and Survivorship Care for Patients With Metastatic Cancer Treated With Radiation Therapy.

Journal: Anticancer research
Published: January 06, 2023

Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma.

Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 07, 2022

Improving Survival Prognostication in Patients With Metastatic Cancer Through Clinical Judgment.

Improving Survival Prognostication in Patients With Metastatic Cancer Through Clinical Judgment.

Journal: Anticancer research
Published: December 30, 2021
Showing 1-12 of 36

Last Updated: 09/26/2026